Status:
NOT_YET_RECRUITING
EB-OCT Biopsy Guidance of Lung Cancer
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Our objective is to develop, test, and validate a clinically robust polarization-sensitive optical coherence tomography (PS-OCT) biopsy guidance and diagnosis platform that is compatible with standard...
Detailed Description
The goal of this study is to improve the unacceptably low diagnostic yield that is associated with low-risk bronchial biopsy. The investigators propose to do this by developing and optimizing a novel ...
Eligibility Criteria
Inclusion
- Patients undergoing elective lung biopsy for known or suspected malignancy in the lung
- Patients must be over the age of 21
- Patient must be able to give informed consent
- Negative pregnancy test for all females of childbearing potential who are sexually active and not using contraception, are seeking to become pregnant, or are nursing
Exclusion
- Patients who are pregnant
- The patient does not meet the requirements to undergo clinical bronchoscopy, as determined by the treating physician.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06556680
Start Date
September 1 2024
End Date
January 1 2027
Last Update
August 27 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.